Broad-spectrum antioxidant peptides derived from His residue-containing sequences present in human paraoxonase 1

References

• La Du BN. Structural and functional diversity of paraoxonase. Nat Med 1996; 2: 1186–1187
   PubMed Web of Science ®Google Scholar
• Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: Basic mechanism, oxidation, inflammation and genetics. Circulation 1995; 9: 2488–2496
   Google Scholar
• Mackness MI, Mackness B, Durrington PA, Connelly PW, Hegele RA. Paraoxonase: Biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69–76
   PubMed Web of Science ®Google Scholar
• Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996; 14: 334–336
   PubMed Web of Science ®Google Scholar
• Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Drug Metab Dispos 1991; 19: 100–106
   PubMed Web of Science ®Google Scholar
• Billecke SD, Draganov R, Counsell P, Stetson C, Watson C, La Du BN. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 2000; 28: 1335–1342
   PubMed Web of Science ®Google Scholar
• Teiber JF, Draganov DI, La Du BN. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem Pharmacol 2003; 66: 887–896
   PubMed Web of Science ®Google Scholar
• Watson AD, Berliner JA, Hama SY, La Du BN, Fauli KF, Fogelman AM, Mohamad N. Protective effect of high density lipoprotein associated paraoxnase: Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Investig 1995; 96: 2882–2891
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du BN. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999; 26: 892–904
   PubMed Web of Science ®Google Scholar
• Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284–287
   PubMed Web of Science ®Google Scholar
• Shih DM, Gu L, Hama S, Xia YR, Navab M, Fogelman AM, Lusis AJ. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Investig 1996; 97: 1630–1639
   PubMed Web of Science ®Google Scholar
• Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M. Human serum paraoxnase (PON 1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circlulation 2000; 101: 2510–2517
   PubMed Web of Science ®Google Scholar
• Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P. Gln–Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 30: 869–872
   Google Scholar
• Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E, Roberts C, Durrington PN, Mackness MI. Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype?. Arterioscler Thromb Vasc Biol 2001; 21: 1451–1457
   PubMed Web of Science ®Google Scholar
• Marathe GK, Zimmerman GA, McIntyre TM. PAF acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 2003; 278: 3937–3947
   PubMed Web of Science ®Google Scholar
• Connelly PW, Draganov D, Maguire GF. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. Free Radic Biol Med 2005; 38: 164–174
   PubMed Web of Science ®Google Scholar
• Teiber JF, Draganov DI, La Du BN. Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH. J Lipid Res 2004; 45: 2260–2268
   PubMed Web of Science ®Google Scholar
• Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke S, La Du BN. Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol 1999; 19: 2214–2225
   PubMed Web of Science ®Google Scholar
• Nguyen SD, Sok DE. Beneficial effect of oleoylated lipids on paraoxonase1: Protection against oxidative inactivation and stabilization. Biochem J 2003; 375: 275–285
   PubMed Web of Science ®Google Scholar
• Nguyen SD, Sok DE. Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids. J Lipid Res 2004; 45: 2211–2220
   PubMed Web of Science ®Google Scholar
• Kuo CL, La Du BN. Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 1995; 23: 935–944
   PubMed Web of Science ®Google Scholar
• Debord J, Bollinger JC, Merle L, Dantoine T. Inhibition of human serum arylesterase by metal chlorides. J Inorg Biochem 2003; 94: 1–4
   PubMed Web of Science ®Google Scholar
• Nguyen SD, Sok DE. Oxidative inactivation of paraoxnase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 2003; 37: 1319–1330
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Thomas GW, Rael LT, Lau EP, Winkler JV. Asp–Ala–His–Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening. Biochem Biophys Res Commun 2001; 28: 356–360
   Google Scholar
• Halliwell B. Albumin—an important extracellular antioxidant?. Biochem Pharmacol 1988; 37: 569–571
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin: An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268: 42–47
   PubMedGoogle Scholar
• Bar-Or D, Rael LT, Lau EP, Rao NK, Thomas GW, Winkler JV, Yukl RL, Kingston RG, Curtis CG. An analog of the human albumin N-terminus (Asp–Ala–His–Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun 2001; 284: 856–862
   PubMed Web of Science ®Google Scholar
• Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci USA 1988; 85: 3175–3179
   PubMed Web of Science ®Google Scholar
• Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003; 25: 259–274
   PubMed Web of Science ®Google Scholar
• Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Methods Enzymol 1986; 128: 155–170
   PubMed Web of Science ®Google Scholar
• Bollag DM, Michael DR, Stuart JE. Protein methods2nd. Wiley-Liss, New York 1996
   Google Scholar
• Turkington RW, Tracy FM. Spectrophotometric determination of ultramicro amounts of copper with 1,5-diphenylcarbohydrazide. Anal Chem 1958; 30: 1699–1701
   Web of Science ®Google Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Radic Res Commun 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983; 8: 1070–1076
   Google Scholar
• Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–421
   PubMed Web of Science ®Google Scholar
• Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276–287
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres VJ, Feather-stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Steel RGD, Torrie JH. Principles and procedures of statistics. McGraw-Hill, New York 1960; 99–132
   Google Scholar
• Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol 1994; 233: 469–489
   PubMed Web of Science ®Google Scholar
• Lass A, Witting P, Stocker R, Esterbauer H. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: Antioxidant actions in addition to hydroperoxide-reducing activity. Biochim Biophys Acta 1996; 1303: 111–118
   PubMed Web of Science ®Google Scholar
• Ma YS, Chao CC, Stadtman ER. Oxidative modification of glutamine synthetase by 2,2′-azo bis (2-amidinopropane) dihydrochloride: Loss of 2 of 16 histidine residues, 6 of 17 tyrosine residues, 5 of 16 methionine residues, and all of the tryptophan residues (2 residues). Arch Biochem Biophys 1999; 363: 129–134
   PubMed Web of Science ®Google Scholar
• Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E. Free radical damage to proteins: The influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radic Biol Med 1991; 11: 161–168
   PubMed Web of Science ®Google Scholar
• Gebicki S, Gebicki JM. Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem J 1993; 289: 743–749
   PubMed Web of Science ®Google Scholar
• Den Hartog GJ, Vegt E, Van der Vijgh WJ, Haenen GR, Bast A. Hypochlorous acid is a potent inhibitor of acetylcholinesterase. Toxicol Appl Pharmacol 2002; 181: 228–332
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Vaya J, Shih D, Aviram M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine. Atherosclerosis 2005; 179: 69–77
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004; 37: 1304–1316
   PubMed Web of Science ®Google Scholar
• Burkitt MJ. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: Roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch Biochem Biophys 2001; 394: 117–135
   PubMed Web of Science ®Google Scholar
• Wagner P, Heinecke JW. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL. Arterioscler Thromb Vasc Biol 1997; 17: 3338–3346
   PubMed Web of Science ®Google Scholar
• van Himbergen TM, van Tits LJ, Hectors MP, de Graaf J, Roest M, Stalenhoef AF. Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia. Biochem Biophys Res Commun 2005; 333: 787–793
   PubMed Web of Science ®Google Scholar
• Kwon HY, Choi SY, Won MH, Kang T, Kang JH. Lysine, histidine, proline, and valine residues were sensitive to AAPH. Biochim Biophys Acta 2000; 1543: 69–76
   PubMed Web of Science ®Google Scholar
• Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000; 28: 1717–1725
   PubMed Web of Science ®Google Scholar
• Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Investig 1996; 97: 1535–1544
   PubMed Web of Science ®Google Scholar
• Pattison DI, Hawkins CL, Davies MJ. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: Absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol 2003; 16: 439–449
   PubMed Web of Science ®Google Scholar
• Bergt C, Fu X, Huq NP, Kao J, Heinecke JW. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 2004; 279: 7856–7866
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ. Kinetic analysis of the role of histidine chloramines in hypochlorous acid mediated protein oxidation. Biochemistry 2005; 44: 7378–7387
   PubMed Web of Science ®Google Scholar